Skip to main content
TECON BIOLOGY Co.LTD logo

TECON BIOLOGY Co.LTD — Investor Relations & Filings

Ticker · 002100 ISIN · CNE000001PZ9 Shenzhen Stock Exchange Manufacturing
Filings indexed 2,493 across all filing types
Latest filing 2021-12-06 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 002100

About TECON BIOLOGY Co.LTD

https://www.tcsw.com.cn

TECON BIOLOGY Co.LTD operates an integrated industrial chain focused on animal health and nutrition. The company specializes in the research, development, and manufacturing of veterinary biological products, including a comprehensive range of vaccines and diagnostic reagents for livestock. Its operations encompass the production of high-quality animal feed and the management of large-scale breeding programs, with a primary focus on pig farming and meat processing. By leveraging advanced biotechnology and standardized production systems, the company provides comprehensive solutions for livestock management and food safety. Key activities include the formulation of specialized animal nutrition products and the implementation of rigorous biosecurity protocols across its facilities to ensure the quality and reliability of its agricultural outputs.

Recent filings

Filing Released Lang Actions
2021年度为全资公司提供银行借款担保的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Tian Kang Biological Co., Ltd. regarding the provision of guarantees for bank loans to its wholly-owned subsidiary for the year 2021. It includes details about the guarantee amount, the relationship between the guarantor and the guaranteed party, financial data of the subsidiary, board approval, and cumulative guarantee amounts. The document is a formal announcement of a financing-related guarantee decision, not a full financial report or audit. It does not contain comprehensive financial statements or detailed financial analysis. The document length is relatively short (2579 characters) and it is focused on a specific financing guarantee event. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2021-12-06 Chinese
关于签订募集资金三方监管协议的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the signing of a tripartite supervision agreement for raised funds related to a non-public stock issuance by Tian Kang Biological Co., Ltd. It details the amount raised, the opening of special accounts for the funds, and the terms of the supervision agreement among the company, banks, and the sponsoring securities firm. There are no financial statements, earnings data, or management discussion of results. The document is a regulatory announcement about fundraising and fund management compliance, not a financial report or earnings release. It fits best under Capital/Financing Update (CAP) as it concerns fundraising activities and capital management.
2021-11-30 Chinese
关于签订募集资金三方监管协议的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the signing of a tripartite supervision agreement for raised funds related to a non-public stock issuance by Tian Kang Biological Co., Ltd. It details the amount raised, the opening of special accounts for the funds, and the terms of the supervision agreement among the company, banks, and the sponsoring securities firm. The document does not contain financial statements or detailed financial performance data but rather focuses on the management and regulatory compliance of the fundraising proceeds. The length is 3281 characters, which is relatively short and the content is an announcement of an agreement related to capital raising. Therefore, this fits best under the category of Capital/Financing Update (CAP).
2021-11-23 Chinese
第七届董事会第二十次(临时)会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of the resolutions passed at the 20th interim meeting of the 7th Board of Directors of Tian Kang Biological Co., Ltd. It details the approval of establishing special accounts for raised funds and signing a tripartite supervision agreement related to a non-public stock issuance. The document includes voting results and references compliance with company law and stock exchange rules. It is not a full annual or interim report, nor a financial statement, but rather a board meeting resolution announcement. Therefore, it fits best under Board/Management Information (MANG). The document length is short and it is not a report publication announcement or certification. Hence, the classification is MANG with high confidence.
2021-11-22 Chinese
关于公司高级管理人员辞职的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of a senior management member (the company's vice general manager). It includes details about the resignation date, the reason, and the impact on the company. There is no financial data, no mention of a report or meeting, and it is clearly about a change in senior management. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and focused solely on management change, confirming this classification.
2021-11-10 Chinese
关于2021年10月份生猪销售简报
Regulatory Filings Classification · 95% confidence The document is a sales brief for October 2021 from Tian Kang Biological Co., Ltd., detailing monthly sales volume and revenue of live pigs, with explanations and risk warnings. It is a short announcement (899 characters) providing operational sales data for a specific month, not a comprehensive financial report or earnings release. It does not contain full financial statements or detailed analysis typical of Interim/Quarterly Reports (IR) or Earnings Releases (ER). It is also not an announcement of a report publication but a standalone sales update. Therefore, it fits best as a Regulatory Filing (RNS), which covers miscellaneous regulatory announcements and operational updates that do not fit other categories.
2021-11-09 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.